Hematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsStem CellsBone Marrow TransplantationTransplantation, AutologousBone Marrow CellsBone MarrowTissue DonorsStem Cell TransplantationGraft vs Leukemia EffectTransplantation ChimeraGraft SurvivalHematopoiesisTreatment OutcomeWhole-Body IrradiationLeukemiaHistocompatibilityGraft vs Tumor EffectMyeloablative AgonistsBusulfanChimerismAllograftsRetrospective StudiesHistocompatibility TestingRecurrencePeripheral Blood Stem Cell TransplantationHematologic DiseasesMice, Inbred C57BLCell DifferentiationVidarabineMyelodysplastic SyndromesFlow CytometryLeukemia, Myeloid, AcuteCytomegalovirus InfectionsAntigens, CD34Hematopoietic Stem Cell MobilizationLymphocyte TransfusionTime FactorsT-LymphocytesCell LineageCord Blood Stem Cell TransplantationHLA AntigensStem Cell NicheColony-Forming Units AssaySiblingsAdult Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem CellsAcute DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCells, CulturedTransplantation ImmunologyTransplantation, IsogeneicSurvival RateRemission InductionAnemia, AplasticCystitisFetal BloodOpportunistic InfectionsSurvival AnalysisGraft RejectionImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLeukemic InfiltrationLymphocyte DepletionCytomegalovirusMinor Histocompatibility AntigensStem Cell FactorCell SeparationCombined Modality TherapyFollow-Up StudiesLymphoproliferative DisordersMultipotent Stem CellsImmunosuppressionIsoantigensBronchiolitis ObliteransPluripotent Stem CellsSevere Combined ImmunodeficiencyCyclophosphamideImmunocompromised HostNeoplasm, ResidualMycosesDisease-Free SurvivalCell ProliferationAntilymphocyte SerumRisk FactorsRadiation ChimeraMice, SCIDLeukemia, MyeloidImmunophenotypingThymus GlandMultiple MyelomaKidney TransplantationHematopoietic SystemPrimary MyelofibrosisSalvage Therapy